Global Granular Riboflavin Market Growth 2024-2030

Global Granular Riboflavin Market Growth 2024-2030

The global Granular Riboflavin market size is projected to grow from US$ 5101 million in 2024 to US$ 7103 million in 2030; it is expected to grow at a CAGR of 5.7% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Granular Riboflavin Industry Forecast” looks at past sales and reviews total world Granular Riboflavin sales in 2023, providing a comprehensive analysis by region and market sector of projected Granular Riboflavin sales for 2024 through 2030. With Granular Riboflavin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Granular Riboflavin industry.

This Insight Report provides a comprehensive analysis of the global Granular Riboflavin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Granular Riboflavin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Granular Riboflavin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Granular Riboflavin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Granular Riboflavin.

United States market for Granular Riboflavin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Granular Riboflavin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Granular Riboflavin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Granular Riboflavin players cover DSM, BASF, NB Group, Merck KGaA, Hubei Guangji Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Granular Riboflavin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
80%≤Riboflavin Content<95%
Riboflavin Content≥95%

Segmentation by Application:
Feed Additives
Food Additives
Drugs
Cosmetics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DSM
BASF
NB Group
Merck KGaA
Hubei Guangji Pharmaceutical
Shanghai Acebright Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Granular Riboflavin market?

What factors are driving Granular Riboflavin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Granular Riboflavin market opportunities vary by end market size?

How does Granular Riboflavin break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.